Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Cell Death & Disease|August 22, 2019
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancerMarina Kazantseva, Sunali Mehta, Ramona A Eiholzer, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian PopulationTamkin Ahmadzada, Wendy A Cooper, Mikaela Holmes, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Redox Biology|November 20, 2019
Phenotypic screen for oxygen consumption rate identifies an anti-cancer naphthoquinone that induces mitochondrial oxidative stressFrances L Byrne, Ellen M Olzomer, Gabriella R Marriott, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Pageof 9